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Ahe Leducq Foundation was founded in 1996 in Paris,
rance, by Jean and Sylviane Leducq, who charged it with
he mission of improving human health through interna-
ional efforts to combat cardiovascular disease. Jean Leducq
as a visionary businessman who, over the course of more
han 50 years, built in Europe and in the U.S. a series of
nterprises involving the care and supply of linens and
niforms. The Leducqs’ international experience, and love
or both continents, became the inspiration for the founda-
ion, its particular organization, and its transcontinental
ision.
With the help of several physician friends and advisers,
he Leducqs and the newly constituted foundation board
ssembled an international Scientific Advisory Committee,
omprising 14 experts in cardiovascular disease, 7 based in
urope, and 7 in the U.S. The founding members included:
Dr. Robert Wallace, President,
Georgetown University, U.S.
Dr. Eugene Braunwald, Harvard University, U.S.
Dr. Robert Frye, Mayo Clinic, U.S.
Dr. Kenneth Mann, University of Vermont, U.S.
Dr. Eugene Passamani, Suburban Hospital, U.S.
Dr. Eric Rose, Columbia University, U.S.
Dr. Andrew Wechsler, MCP Hahnemann
University Hospital, U.S.
Dr. Gunter Breithardt, University of Münster, Germany
Dr. Pierre Corvol, Collège de France, France
Dr. Kim Fox, Royal Brompton & Harefields NHS Trust,
U.K.
Dr. Claude Griscelli, Institut Necker, France
Dr. Michel Komajda, Hôpital Pitié-La-Salpêtrière,
France
Dr. Gabriel Steg, Hôpital Bichat, France
Dr. Marko Turina, Universität Spital, Switzerland
hese members guided the foundation through the chal-
enging initial stages of its development and launched the
rant program that provided the impetus for this publica-
ion. Ultimately they helped to orient the foundation toward
new grant program that emphasizes to a greater degree the
nternational aspect of the foundation.
In June 1999, the Leducq Foundation awarded its first
rants in cardiovascular research. The grant program was
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ccepted May 1, 2006.imed at providing support to individual investigators in
urope or in the U.S. for work on what the foundation’s
cientific Advisory Committee had identified as critical
ssues for cardiovascular research:
Molecular and genetic epidemiology of cardiovascular
diseases with emphasis on human populations
Diabetes and cardiovascular diseases, including pre-
diabetic state
Heart failure
Epidemiology and outcome analysis of cardiovascular
care emphasizing gender, ethnicity, and geographical
variations, as well as quality improvement
New techniques in cardiovascular surgery, emphasizing
critical evaluation
Genetic management of cardiovascular diseases
ith the second round of awards under this program made
n 2001, a total of 9 investigators received funding under
his first phase of the Leducq Foundation’s grant program.
t is their work, originally presented in Paris in October
005 at the Leducq Symposium: Critical Issues in Cardiovas-
ular Research, that comprises this volume.
To acknowledge that 7 years later the critical issues in
ardiovascular research are still critical is not to impugn the
rogress that has been made over that time. Indeed, the
ollowing pages attest to tremendous advances in our un-
erstanding of the genetic and molecular basis of heart
ailure and arrhythmia, and of the metabolic pathways in
nd the pathogenesis of vascular disease. The objective of
he foundation in publishing this supplement is to provide a
eview of the developments in these areas and to make it
vailable to a wide audience. We are grateful to the editors
f the Journal of the American College of Cardiology for their
ssistance in this endeavor.
In 2003, the Leducq Foundation introduced an innova-
ive program in cardiovascular research: The Transatlantic
etworks of Excellence in Cardiovascular Disease. Under this
nitiative, the foundation awards grants for collaborative
uropean-American cardiovascular research programs.
ach Network of Excellence is built around a strong central
elationship involving a European coordinator and a North
merican coordinator, who jointly direct the research pro-
ram. Other members from both continents are added to
he network to participate in particular research projects. It
s hoped that the international cooperation will allow
nvestigators to pool the often complementary research
fforts and resources available in Europe and North
merica.
The Leducq Foundation awards each network up to6 million (USD) over 5 years to carry out its proposed
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Preface November 7, 2006:A1–2esearch. A total of $24 million per year is currently made
vailable for grants in cardiovascular research. Including the
rograms selected in 2006, there are currently 12 Leducq
esearch networks underway, promising developments in areas
uch as heart failure, atherothrombotic disease, arrhythmia,
ongenital heart disease, and others.
The Transatlantic Networks of Excellence program will
e continued in 2006 to 2007. Beginning in this application
ycle, the Foundation plans to include under its cardiovas-
ular disease mandate research on neurovascular disease, Earticularly acute stroke. Interest in the Transatlantic Net-
ork program is increasing as researchers understand the
ossibilities of collaborative investigations across interna-
ional borders.
Further information about Fondation Leducq is available
n the foundation’s website (www.fondationleducq.org).
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